NASDAQ: AUTL - Autolus Therapeutics plc

Rentabilidad a seis meses: -54.4%
Rendimiento de dividendos: 0.00%
Sector: Healthcare

Noticias
Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.

18 noviembre 17:59 Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.